StockData
Clene Inc. logo

Clene Inc. (CLNN) stock

CLNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$3.22−0.44 (-12.02%)

Close on Nov 17, 2026Market cap $41.37MP/E –Yield –

Clene cash

Cash and short-term investments held at the end of each period.

Clene's cash was $9.70M at Jun 30, 2026. For fiscal 2025 it was $5.20M, down 57.4% from the year before. The highest annual figure on record is $59.28M in fiscal 2020.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.20M-57.4%
FY2024Dec 31, 2024$12.20M-65.1%
FY2023Dec 31, 2023$35.00M+50.2%
FY2022Dec 31, 2022$23.30M-53.7%
FY2021Dec 31, 2021$50.30M-15.1%
FY2020Dec 31, 2020$59.28M+574.5%
FY2019Dec 31, 2019$8.79M-47.6%
FY2018Dec 31, 2018$16.78M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$9.70M+32.9%
Q1 FY2026Mar 31, 2026$5.90M-39.8%
Q4 FY2025Dec 31, 2025$5.20M-57.4%
Q3 FY2025Sep 30, 2025$7.90M-45.9%
Q2 FY2025Jun 30, 2025$7.30M-66.4%
Q1 FY2025Mar 31, 2025$9.80M-64.9%
Q4 FY2024Dec 31, 2024$12.20M-65.1%
Q3 FY2024Sep 30, 2024$14.60M-65.3%
Q2 FY2024Jun 30, 2024$21.70M-55.9%
Q1 FY2024Mar 31, 2024$27.90M+51.6%
Q4 FY2023Dec 31, 2023$35.00M+50.2%
Q3 FY2023Sep 30, 2023$42.10M+60.2%
Q2 FY2023Jun 30, 2023$49.20M+34.7%
Q1 FY2023Mar 31, 2023$18.40M-63.4%
Q4 FY2022Dec 31, 2022$23.30M-61.5%
Q2 FY2022Jun 30, 2022$26.29M-58.3%
Q1 FY2022Mar 31, 2022$36.52M-24.0%
Q4 FY2021Dec 31, 2021$50.30M-15.1%
Q3 FY2021Sep 30, 2021$60.55M+64.6%
Q2 FY2021Jun 30, 2021$63.01M+814.6%
Q1 FY2021Mar 31, 2021$48.04M+575.1%
Q4 FY2020Dec 31, 2020$59.28M+574.5%
Q3 FY2020Sep 30, 2020$36.78M+119.2%
Q2 FY2020Jun 30, 2020$6.89M–
Q1 FY2020Mar 31, 2020$7.12M–
Q4 FY2019Dec 31, 2019$8.79M–
Q4 FY2018Dec 31, 2018$16.78M–

More Clene figures

See a number that looks wrong?